<span style="color: #222222;">Indigenous Indian COVID 19 vaccines are in the global race to end the corinavirus pandemic. Science and Technology Ministry said that a silver lining has appeared with the announcement of COVAXIN by Bharat Biotech and ZyCov-D Vaccine by Zydus Cadila.  Drug Controller General of India CDSCO, has given the nod for the conduct of the human trial for the vaccines.</span><br />'' <br />'' <span style="color: #222222;">In the past years, India has emerged as one of the significant vaccine manufacturing hubs. Indian manufacturers account for 60 percent of vaccine supplies made to UNICEF. Across the world, more than 140 candidate vaccines are under various stages of development. </span><br />'' <br />'' <span style="color: #222222;">Indian institutions have also engaged in Research and Development for the development of vaccines in India. With the primary scientific inputs coming from institutions like Pune based ICMR institution National Institute of Virology and Hyderabad based CSIR institution Center for Cellular and Molecular Biology, six Indian companies are working on a vaccine for COVID-19. Along with COVAXIN and ZyCov-D, 11 out of 140 vaccine candidates have entered the human trials world over.</span><br />''